nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP2D6—Parkinson's disease	0.49	0.583	CbGaD
Fesoterodine—ABCB1—Parkinson's disease	0.35	0.417	CbGaD
Fesoterodine—CHRM4—head—Parkinson's disease	0.000688	0.0475	CbGeAlD
Fesoterodine—CHRM4—nervous system—Parkinson's disease	0.000653	0.0451	CbGeAlD
Fesoterodine—CHRM2—forebrain—Parkinson's disease	0.000645	0.0445	CbGeAlD
Fesoterodine—CHRM4—central nervous system—Parkinson's disease	0.000628	0.0434	CbGeAlD
Fesoterodine—CHRM1—forebrain—Parkinson's disease	0.000587	0.0405	CbGeAlD
Fesoterodine—CHRM2—cardiovascular system—Parkinson's disease	0.000545	0.0377	CbGeAlD
Fesoterodine—CHRM5—head—Parkinson's disease	0.000538	0.0372	CbGeAlD
Fesoterodine—CHRM3—forebrain—Parkinson's disease	0.000525	0.0363	CbGeAlD
Fesoterodine—CYP2D6—hindbrain—Parkinson's disease	0.000514	0.0355	CbGeAlD
Fesoterodine—CHRM5—nervous system—Parkinson's disease	0.00051	0.0352	CbGeAlD
Fesoterodine—CHRM4—brain—Parkinson's disease	0.000499	0.0345	CbGeAlD
Fesoterodine—CHRM1—cardiovascular system—Parkinson's disease	0.000497	0.0343	CbGeAlD
Fesoterodine—CHRM5—central nervous system—Parkinson's disease	0.000491	0.0339	CbGeAlD
Fesoterodine—CHRM5—brain—Parkinson's disease	0.00039	0.0269	CbGeAlD
Fesoterodine—CHRM2—head—Parkinson's disease	0.000369	0.0255	CbGeAlD
Fesoterodine—CHRM2—nervous system—Parkinson's disease	0.00035	0.0242	CbGeAlD
Fesoterodine—CHRM2—central nervous system—Parkinson's disease	0.000337	0.0233	CbGeAlD
Fesoterodine—CHRM1—head—Parkinson's disease	0.000336	0.0232	CbGeAlD
Fesoterodine—CHRM1—nervous system—Parkinson's disease	0.000319	0.022	CbGeAlD
Fesoterodine—CHRM1—central nervous system—Parkinson's disease	0.000307	0.0212	CbGeAlD
Fesoterodine—CHRM3—head—Parkinson's disease	0.000301	0.0208	CbGeAlD
Fesoterodine—CYP2D6—brainstem—Parkinson's disease	0.000294	0.0203	CbGeAlD
Fesoterodine—CHRM3—nervous system—Parkinson's disease	0.000285	0.0197	CbGeAlD
Fesoterodine—CYP2D6—forebrain—Parkinson's disease	0.000284	0.0196	CbGeAlD
Fesoterodine—CHRM3—central nervous system—Parkinson's disease	0.000275	0.019	CbGeAlD
Fesoterodine—CHRM2—brain—Parkinson's disease	0.000268	0.0185	CbGeAlD
Fesoterodine—CHRM1—brain—Parkinson's disease	0.000244	0.0168	CbGeAlD
Fesoterodine—ABCB1—embryo—Parkinson's disease	0.000231	0.016	CbGeAlD
Fesoterodine—CHRM3—brain—Parkinson's disease	0.000218	0.0151	CbGeAlD
Fesoterodine—ABCB1—forebrain—Parkinson's disease	0.000204	0.0141	CbGeAlD
Fesoterodine—ABCB1—cardiovascular system—Parkinson's disease	0.000173	0.0119	CbGeAlD
Fesoterodine—CYP2D6—head—Parkinson's disease	0.000163	0.0112	CbGeAlD
Fesoterodine—CYP3A4—nervous system—Parkinson's disease	0.000157	0.0108	CbGeAlD
Fesoterodine—CYP2D6—nervous system—Parkinson's disease	0.000154	0.0107	CbGeAlD
Fesoterodine—CYP3A4—central nervous system—Parkinson's disease	0.000151	0.0104	CbGeAlD
Fesoterodine—CYP2D6—central nervous system—Parkinson's disease	0.000149	0.0103	CbGeAlD
Fesoterodine—ABCB1—medulla oblongata—Parkinson's disease	0.000148	0.0102	CbGeAlD
Fesoterodine—CYP2D6—cerebellum—Parkinson's disease	0.000145	0.01	CbGeAlD
Fesoterodine—ABCB1—midbrain—Parkinson's disease	0.000135	0.00932	CbGeAlD
Fesoterodine—ABCB1—spinal cord—Parkinson's disease	0.000132	0.00909	CbGeAlD
Fesoterodine—CYP2D6—brain—Parkinson's disease	0.000118	0.00814	CbGeAlD
Fesoterodine—ABCB1—head—Parkinson's disease	0.000117	0.00808	CbGeAlD
Fesoterodine—ABCB1—nervous system—Parkinson's disease	0.000111	0.00766	CbGeAlD
Fesoterodine—ABCB1—central nervous system—Parkinson's disease	0.000107	0.00738	CbGeAlD
Fesoterodine—ABCB1—cerebellum—Parkinson's disease	0.000104	0.00721	CbGeAlD
Fesoterodine—ABCB1—brain—Parkinson's disease	8.48e-05	0.00586	CbGeAlD
Fesoterodine—CHRM3—Signaling Pathways—MAG—Parkinson's disease	4.54e-05	0.000312	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PENK—Parkinson's disease	4.54e-05	0.000312	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	4.52e-05	0.000311	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	4.51e-05	0.00031	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—INSR—Parkinson's disease	4.5e-05	0.00031	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	4.5e-05	0.00031	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	4.5e-05	0.00031	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	4.49e-05	0.000309	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	4.49e-05	0.000309	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	4.49e-05	0.000309	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	4.49e-05	0.000309	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	4.48e-05	0.000308	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PLA2G6—Parkinson's disease	4.47e-05	0.000307	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	4.46e-05	0.000307	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	4.44e-05	0.000306	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	4.44e-05	0.000306	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MAOB—Parkinson's disease	4.42e-05	0.000304	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.38e-05	0.000301	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—INSR—Parkinson's disease	4.31e-05	0.000297	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—DBH—Parkinson's disease	4.28e-05	0.000294	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.28e-05	0.000294	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GBA—Parkinson's disease	4.28e-05	0.000294	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—FGB—Parkinson's disease	4.26e-05	0.000293	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—HTR2A—Parkinson's disease	4.25e-05	0.000292	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR1A—Parkinson's disease	4.23e-05	0.000291	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.22e-05	0.00029	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	4.21e-05	0.000289	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TAC1—Parkinson's disease	4.17e-05	0.000287	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	4.17e-05	0.000287	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	4.16e-05	0.000286	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	4.15e-05	0.000285	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	4.11e-05	0.000283	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD1—Parkinson's disease	4.09e-05	0.000281	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	4.09e-05	0.000281	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	4.09e-05	0.000281	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—FGB—Parkinson's disease	4.08e-05	0.00028	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	4.08e-05	0.00028	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	4.08e-05	0.00028	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.07e-05	0.00028	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	4.07e-05	0.00028	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	4.06e-05	0.000279	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	4.04e-05	0.000278	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	4.04e-05	0.000278	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	3.99e-05	0.000275	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.97e-05	0.000273	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD3—Parkinson's disease	3.96e-05	0.000272	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	3.92e-05	0.000269	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	3.91e-05	0.000269	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	3.9e-05	0.000268	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	3.87e-05	0.000266	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	3.86e-05	0.000266	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	3.86e-05	0.000265	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	3.82e-05	0.000263	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.81e-05	0.000262	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	3.79e-05	0.000261	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.74e-05	0.000257	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ADRBK1—Parkinson's disease	3.7e-05	0.000254	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ND3—Parkinson's disease	3.69e-05	0.000254	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.69e-05	0.000254	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	3.62e-05	0.000249	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	3.6e-05	0.000248	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	3.59e-05	0.000247	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR7—Parkinson's disease	3.58e-05	0.000246	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DRD2—Parkinson's disease	3.58e-05	0.000246	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	3.56e-05	0.000245	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	3.54e-05	0.000244	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.47e-05	0.000239	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—OMD—Parkinson's disease	3.47e-05	0.000239	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.43e-05	0.000236	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	3.43e-05	0.000236	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	3.43e-05	0.000236	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.42e-05	0.000235	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	3.39e-05	0.000233	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	3.38e-05	0.000233	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	3.35e-05	0.00023	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—DDC—Parkinson's disease	3.33e-05	0.000229	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.31e-05	0.000228	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.29e-05	0.000226	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	3.29e-05	0.000226	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP2D6—Parkinson's disease	3.29e-05	0.000226	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	3.28e-05	0.000226	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	3.27e-05	0.000225	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	3.26e-05	0.000224	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	3.25e-05	0.000223	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	3.23e-05	0.000222	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CTGF—Parkinson's disease	3.23e-05	0.000222	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.15e-05	0.000217	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.15e-05	0.000217	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	3.14e-05	0.000216	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—DDC—Parkinson's disease	3.14e-05	0.000216	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.14e-05	0.000216	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.11e-05	0.000214	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	3.04e-05	0.000209	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—INSR—Parkinson's disease	3.03e-05	0.000208	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP2E1—Parkinson's disease	3.01e-05	0.000207	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	3e-05	0.000206	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	3e-05	0.000206	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NQO1—Parkinson's disease	2.97e-05	0.000204	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.97e-05	0.000204	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.96e-05	0.000203	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—TH—Parkinson's disease	2.93e-05	0.000202	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	2.9e-05	0.0002	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	2.87e-05	0.000198	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	2.87e-05	0.000197	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	2.87e-05	0.000197	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	2.86e-05	0.000197	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGB—Parkinson's disease	2.86e-05	0.000197	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	2.86e-05	0.000196	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	2.85e-05	0.000196	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	2.85e-05	0.000196	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.84e-05	0.000195	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	2.83e-05	0.000195	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	2.83e-05	0.000194	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	2.82e-05	0.000194	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYCS—Parkinson's disease	2.81e-05	0.000193	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	2.81e-05	0.000193	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MAOB—Parkinson's disease	2.81e-05	0.000193	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	2.8e-05	0.000193	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.8e-05	0.000192	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.8e-05	0.000192	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.8e-05	0.000192	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	2.78e-05	0.000191	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	2.78e-05	0.000191	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	2.76e-05	0.00019	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	2.75e-05	0.000189	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	2.75e-05	0.000189	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	2.72e-05	0.000187	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.67e-05	0.000184	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	2.67e-05	0.000184	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	2.66e-05	0.000183	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.64e-05	0.000182	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	2.64e-05	0.000181	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NGF—Parkinson's disease	2.64e-05	0.000181	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NGF—Parkinson's disease	2.52e-05	0.000174	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	2.51e-05	0.000173	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	2.49e-05	0.000172	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—COMT—Parkinson's disease	2.49e-05	0.000171	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	2.49e-05	0.000171	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTP1—Parkinson's disease	2.48e-05	0.000171	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MAOA—Parkinson's disease	2.47e-05	0.00017	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	2.46e-05	0.000169	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—HMOX1—Parkinson's disease	2.45e-05	0.000168	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	2.42e-05	0.000166	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	2.42e-05	0.000166	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	2.41e-05	0.000166	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	2.41e-05	0.000166	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	2.4e-05	0.000165	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	2.38e-05	0.000164	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	2.38e-05	0.000164	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ABCB1—Parkinson's disease	2.35e-05	0.000161	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APOE—Parkinson's disease	2.33e-05	0.00016	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTM1—Parkinson's disease	2.28e-05	0.000157	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APOE—Parkinson's disease	2.23e-05	0.000154	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GPX1—Parkinson's disease	2.18e-05	0.00015	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.09e-05	0.000143	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—DDC—Parkinson's disease	2.05e-05	0.000141	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CTGF—Parkinson's disease	2.05e-05	0.000141	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	2.02e-05	0.000139	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	2.02e-05	0.000139	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—MTHFR—Parkinson's disease	2.01e-05	0.000138	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	2e-05	0.000137	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—INS—Parkinson's disease	1.99e-05	0.000137	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	1.96e-05	0.000135	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	1.95e-05	0.000134	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.94e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	1.93e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	1.93e-05	0.000133	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.93e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	1.93e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	1.91e-05	0.000131	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—INS—Parkinson's disease	1.91e-05	0.000131	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.91e-05	0.000131	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.89e-05	0.00013	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—APOE—Parkinson's disease	1.87e-05	0.000129	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TH—Parkinson's disease	1.86e-05	0.000128	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.8e-05	0.000124	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYCS—Parkinson's disease	1.79e-05	0.000123	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.78e-05	0.000122	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	1.78e-05	0.000122	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	1.77e-05	0.000122	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	1.75e-05	0.000121	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TH—Parkinson's disease	1.75e-05	0.00012	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.75e-05	0.00012	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.73e-05	0.000119	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	1.69e-05	0.000116	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	1.69e-05	0.000116	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.68e-05	0.000116	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	1.67e-05	0.000115	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—INS—Parkinson's disease	1.6e-05	0.00011	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—COMT—Parkinson's disease	1.58e-05	0.000109	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.57e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	1.57e-05	0.000108	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MAOA—Parkinson's disease	1.57e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	1.57e-05	0.000108	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	1.55e-05	0.000107	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.55e-05	0.000107	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.49e-05	0.000102	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	1.48e-05	0.000102	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.48e-05	0.000102	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.48e-05	0.000102	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	1.47e-05	0.000101	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.46e-05	0.000101	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.45e-05	9.94e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	1.42e-05	9.77e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	1.41e-05	9.71e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.4e-05	9.65e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GPX1—Parkinson's disease	1.38e-05	9.52e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	1.36e-05	9.38e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.36e-05	9.37e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—INS—Parkinson's disease	1.34e-05	9.24e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—INS—Parkinson's disease	1.34e-05	9.21e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—INS—Parkinson's disease	1.33e-05	9.12e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	1.31e-05	8.98e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.3e-05	8.97e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.29e-05	8.84e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.28e-05	8.79e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.26e-05	8.68e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.2e-05	8.28e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—Parkinson's disease	1.19e-05	8.18e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.18e-05	8.08e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.16e-05	7.99e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TH—Parkinson's disease	1.15e-05	7.88e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.12e-05	7.71e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.1e-05	7.56e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—INS—Parkinson's disease	1.02e-05	6.99e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1e-05	6.88e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	9.97e-06	6.86e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	9.94e-06	6.83e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	9.91e-06	6.81e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	9.87e-06	6.79e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	9.81e-06	6.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—COMT—Parkinson's disease	9.74e-06	6.7e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	9.69e-06	6.67e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MAOA—Parkinson's disease	9.67e-06	6.65e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—INS—Parkinson's disease	9.58e-06	6.59e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	9.56e-06	6.57e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	9.19e-06	6.32e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	9.18e-06	6.31e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	9.16e-06	6.3e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	9.08e-06	6.24e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.91e-06	6.13e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—Parkinson's disease	8.71e-06	5.99e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.53e-06	5.87e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	8.34e-06	5.73e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.87e-06	5.41e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—Parkinson's disease	7.33e-06	5.04e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—INS—Parkinson's disease	6.26e-06	4.31e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	5.87e-06	4.04e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	5.85e-06	4.02e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	5.8e-06	3.99e-05	CbGpPWpGaD
